Bristol-Myers (BMY) Wins Ruling Blocking Generic Plavix

June 19, 2007 9:34 AM EDT

Bristol-Myers Squibb Co. (NYSE: BMY) and Sanofi-Aventis (NYSE: SNY) won a trial blocking generic competition on top selling blood-thinner Plavix. The court rejected Apotex\'s claim that the patent is invalid or unenforceable.


Related Categories

FDA

Stocks Mentioned

BMY 27.59

+7.35 +36.31%
Volume: 440,849
Track BMY

SNY 27.56

-2.78 -9.16%
Volume: 445,764
Track SNY


Add Your Comment